Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Agilent Technologies, Inc. (A) vs Quest Diagnostics Incorporated (DGX)

Agilent Technologies, Inc. and Quest Diagnostics Incorporated are both Diagnostics & Research companies. Agilent Technologies, Inc. is the larger, with a market value of $49.0B against $26.2B — 1.9× the size. Quest Diagnostics Incorporated trades at the lower P/E: 24.8× against 33.9×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.87% against 8.60%. Agilent Technologies, Inc. has the higher net margin (19.5% vs 9.15%) and the higher return on invested capital (11.1% vs 7.94%). Both pay a dividend; Quest Diagnostics Incorporated yields more (2.30% vs 0.70%). Across the 23 metrics below, Agilent Technologies, Inc. leads on 12 and Quest Diagnostics Incorporated on 11.

Valuation

Metric A DGX Diagnostics & Research median
P/E 33.95 24.77 33.95
P/S 6.61 2.27 4.87
P/B 6.62 3.35 3.12
Price to free cash flow 38.40 19.45 34.02
EV/EBITDA 26.50 14.14 25.20
EV/Sales 6.87 2.70 5.66
Earnings yield 2.95% 4.04% (1.75%)
Free cash flow yield 2.60% 5.14% (0.13%)

Profitability

Metric A DGX Diagnostics & Research median
Gross margin 53.83% 33.11% 50.89%
Operating margin 22.23% 14.10% (8.57%)
Net margin 19.53% 9.15% (6.37%)
Free cash flow margin 17.19% 11.67% 0.00%
Return on equity 20.97% 14.03% (2.92%)
Return on assets 11.00% 6.43% (6.71%)
Return on invested capital 11.07% 7.94% 0.00%

Growth

Metric A DGX Diagnostics & Research median
Revenue growth (TTM) 8.60% 9.87% 7.69%
EPS growth (last fiscal year) 3.16% 13.78% —
Revenue growth, 5-year CAGR 5.41% 3.18% 7.40%
Net income growth, 5-year CAGR 12.63% (7.06%) 0.00%

Health

Metric A DGX Diagnostics & Research median
Debt to equity 0.50 0.72 0.11
Current ratio 2.05 1.59 2.02
Net debt to EBITDA 0.71 2.47 0.78

Dividend

Metric A DGX Diagnostics & Research median
Dividend yield 0.70% 2.30% 0.70%
Payout ratio 0.23 0.29 0.00

Size

Metric A DGX Diagnostics & Research median
Market cap 49.02b 26.19b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack